Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced B-cell Lymphoid Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04029038
What this trial is testing

Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma

Who this might be right for
CD19 PositiveCD22 PositiveMinimal Residual Disease+7 more
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT02352558
What this trial is testing

BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

Who this might be right for
Hematologic Malignancy
Sumitomo Pharma America, Inc. 15
Early research (Phase 1)Study completedNCT00025415
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAIDS-related Peripheral/Systemic Lymphoma+78 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00373906
What this trial is testing

Velcade in MALT Lymphoma Patients

Who this might be right for
MALT Lymphoma
Medical University of Vienna 16
Testing effectiveness (Phase 2)Study completedNCT00248430
What this trial is testing

Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+1 more
Fred Hutchinson Cancer Center 20
Early research (Phase 1)UnknownNCT00090727
What this trial is testing

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Solid MalignanciesNon-Hodgkin's Lymphoma
Novacea 45
Early research (Phase 1)Study completedNCT00303797
What this trial is testing

Sorafenib and Bortezomib in Treating Patients With Advanced Cancer

Who this might be right for
Refractory Chronic Lymphocytic LeukemiaRefractory Multiple MyelomaStage III Multiple Myeloma+2 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00004047
What this trial is testing

Chemotherapy in Treating Patients Who Have Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Daiichi Sankyo
Testing effectiveness (Phase 2)Study completedNCT00365287
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Who this might be right for
Breast CancerKidney CancerLeukemia+3 more
Masonic Cancer Center, University of Minnesota 148
Early research (Phase 1)Ended earlyNCT00003567
What this trial is testing

Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 8
Early research (Phase 1)Study completedNCT00004245
What this trial is testing

Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00004105
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Cancer

Who this might be right for
LeukemiaLymphomaSarcoma+1 more
NYU Langone Health
Early research (Phase 1)Study completedNCT00049400
What this trial is testing

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
SWOG Cancer Research Network 78
Early research (Phase 1)Study completedNCT00003082
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Arizona 27
Testing effectiveness (Phase 2)Ended earlyNCT05348889
What this trial is testing

First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic Malignancies

Who this might be right for
Non-Hodgkin's Lymphoma (disorder)Acute Lymphoid Leukemia, Disease (disorder)
Chimagen Biosciences, Ltd 7
Testing effectiveness (Phase 2)Study completedNCT00006039
What this trial is testing

Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Ended earlyNCT00060112
What this trial is testing

Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+31 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT00003395
What this trial is testing

Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00352443
What this trial is testing

S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
SWOG Cancer Research Network 66
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Next Page